アニデュラファンギンの世界市場 2020年

• 英文タイトル：Global Anidulafungin Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113551 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、アニデュラファンギンの世界市場を調査対象にし、アニデュラファンギンの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（50mg/バイアル、100mg/バイアル）、用途別分析（病院、ドラッグストア）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Pfizer ・企業別売上、市場シェア ・アニデュラファンギンの地域別市場分析 ・アニデュラファンギンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アニデュラファンギンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アニデュラファンギンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アニデュラファンギンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アニデュラファンギンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アニデュラファンギンの種類別市場規模2015-2020：50mg/バイアル、100mg/バイアル ・アニデュラファンギンの用途別市場規模2015-2020：病院、ドラッグストア ・アニデュラファンギンの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Anidulafungin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Anidulafungin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Anidulafungin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Anidulafungin market has been segmented into:
50 mg per vial
100 mg per vial

By Application, Anidulafungin has been segmented into:
Hospital
Drug store

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anidulafungin market presented in the report. This section sheds light on the sales growth of different regional and country-level Anidulafungin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anidulafungin market.

The report offers in-depth assessment of the growth and other aspects of the Anidulafungin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Anidulafungin Market Share Analysis
Anidulafungin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anidulafungin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anidulafungin sales, revenue and market share for each player covered in this report.

The major players covered in Anidulafungin are:
Pfizer

レポート目次

---

1 Anidulafungin Market Overview
1.1 Product Overview and Scope of Anidulafungin
1.2 Classification of Anidulafungin by Type
1.2.1 Global Anidulafungin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anidulafungin Revenue Market Share by Type in 2019
1.2.3 50 mg per vial
1.2.4 100 mg per vial
1.3 Global Anidulafungin Market by Application
1.3.1 Overview: Global Anidulafungin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Anidulafungin Market by Regions
1.4.1 Global Anidulafungin Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anidulafungin (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anidulafungin Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anidulafungin Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anidulafungin Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anidulafungin Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anidulafungin Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Anidulafungin Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anidulafungin Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anidulafungin Players Market Share
3.2.2 Top 10 Anidulafungin Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anidulafungin Revenue and Market Share by Regions
4.2 North America Anidulafungin Revenue and Growth Rate (2015-2020)
4.3 Europe Anidulafungin Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anidulafungin Revenue and Growth Rate (2015-2020)
4.5 South America Anidulafungin Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anidulafungin Revenue and Growth Rate (2015-2020)
5 North America Anidulafungin Revenue by Countries
5.1 North America Anidulafungin Revenue by Countries (2015-2020)
5.2 USA Anidulafungin Revenue and Growth Rate (2015-2020)
5.3 Canada Anidulafungin Revenue and Growth Rate (2015-2020)
5.4 Mexico Anidulafungin Revenue and Growth Rate (2015-2020)
6 Europe Anidulafungin Revenue by Countries
6.1 Europe Anidulafungin Revenue by Countries (2015-2020)
6.2 Germany Anidulafungin Revenue and Growth Rate (2015-2020)
6.3 UK Anidulafungin Revenue and Growth Rate (2015-2020)
6.4 France Anidulafungin Revenue and Growth Rate (2015-2020)
6.5 Russia Anidulafungin Revenue and Growth Rate (2015-2020)
6.6 Italy Anidulafungin Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anidulafungin Revenue by Countries
7.1 Asia-Pacific Anidulafungin Revenue by Countries (2015-2020)
7.2 China Anidulafungin Revenue and Growth Rate (2015-2020)
7.3 Japan Anidulafungin Revenue and Growth Rate (2015-2020)
7.4 Korea Anidulafungin Revenue and Growth Rate (2015-2020)
7.5 India Anidulafungin Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anidulafungin Revenue and Growth Rate (2015-2020)
8 South America Anidulafungin Revenue by Countries
8.1 South America Anidulafungin Revenue by Countries (2015-2020)
8.2 Brazil Anidulafungin Revenue and Growth Rate (2015-2020)
8.3 Argentina Anidulafungin Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anidulafungin by Countries
9.1 Middle East & Africa Anidulafungin Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anidulafungin Revenue and Growth Rate (2015-2020)
9.3 UAE Anidulafungin Revenue and Growth Rate (2015-2020)
9.4 Egypt Anidulafungin Revenue and Growth Rate (2015-2020)
9.5 South Africa Anidulafungin Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anidulafungin Revenue and Market Share by Type (2015-2020)
10.2 Global Anidulafungin Market Forecast by Type (2019-2024)
10.3 50 mg per vial Revenue Growth Rate (2015-2025)
10.4 100 mg per vial Revenue Growth Rate (2015-2025)
11 Global Anidulafungin Market Segment by Application
11.1 Global Anidulafungin Revenue Market Share by Application (2015-2020)
11.2 Anidulafungin Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drug store Revenue Growth (2015-2020)
12 Global Anidulafungin Market Size Forecast (2021-2025)
12.1 Global Anidulafungin Market Size Forecast (2021-2025)
12.2 Global Anidulafungin Market Forecast by Regions (2021-2025)
12.3 North America Anidulafungin Revenue Market Forecast (2021-2025)
12.4 Europe Anidulafungin Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anidulafungin Revenue Market Forecast (2021-2025)
12.6 South America Anidulafungin Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anidulafungin Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Anidulafungin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anidulafungin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anidulafungin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anidulafungin Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Anidulafungin Major Business
Table 7. Pfizer Anidulafungin Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Anidulafungin Product and Solutions
Table 10. Pfizer Anidulafungin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Anidulafungin Revenue (Million USD) by Players (2015-2020)
Table 12. Global Anidulafungin Revenue Share by Players (2015-2020)
Table 13. Global Anidulafungin Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Anidulafungin Revenue Market Share by Regions (2015-2020)
Table 15. North America Anidulafungin Revenue by Countries (2015-2020)
Table 16. North America Anidulafungin Revenue Market Share by Countries (2015-2020)
Table 17. Europe Anidulafungin Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Anidulafungin Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Anidulafungin Revenue by Countries (2015-2020)
Table 20. South America Anidulafungin Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Anidulafungin Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Anidulafungin Revenue Market Share by Countries (2015-2020)
Table 23. Global Anidulafungin Revenue (Million USD) by Type (2015-2020)
Table 24. Global Anidulafungin Revenue Share by Type (2015-2020)
Table 25. Global Anidulafungin Revenue Forecast by Type (2021-2025)
Table 26. Global Anidulafungin Revenue by Application (2015-2020)
Table 27. Global Anidulafungin Revenue Share by Application (2015-2020)
Table 28. Global Anidulafungin Revenue Forecast by Application (2021-2025)
Table 29. Global Anidulafungin Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anidulafungin Picture
Figure 2. Global Anidulafungin Revenue Market Share by Type in 2019
Figure 3. 50 mg per vial Picture
Figure 4. 100 mg per vial Picture
Figure 5. Anidulafungin Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Anidulafungin Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Anidulafungin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Anidulafungin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Anidulafungin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Anidulafungin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Anidulafungin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Anidulafungin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Anidulafungin Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Anidulafungin Revenue Market Share in 2019
Figure 17. Global Top 10 Players Anidulafungin Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Anidulafungin Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Anidulafungin Revenue Market Share by Regions (2015-2020)
Figure 21. Global Anidulafungin Revenue Market Share by Regions in 2018
Figure 22. North America Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 23. Europe Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 25. South America Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 27. North America Anidulafungin Revenue Market Share by Countries (2015-2020)
Figure 28. North America Anidulafungin Revenue Market Share by Countries in 2019
Figure 29. USA Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 30. Canada Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 32. Europe Anidulafungin Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Anidulafungin Revenue Market Share by Countries in 2019
Figure 34. Germany Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 35. UK Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 36. France Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 37. Russia Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 38. Italy Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Anidulafungin Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Anidulafungin Revenue Market Share by Countries in 2019
Figure 41. China Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 42. Japan Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 43. Korea Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 44. India Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 46. South America Anidulafungin Revenue Market Share by Countries (2015-2020)
Figure 47. South America Anidulafungin Revenue Market Share by Countries in 2019
Figure 48. Brazil Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Anidulafungin Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Anidulafungin Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 53. UAE Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Anidulafungin Revenue and Growth Rate (2015-2020)
Figure 56. Global Anidulafungin Revenue Share by Type (2015-2020)
Figure 57. Global Anidulafungin Revenue Share by Type in 2019
Figure 58. Global Anidulafungin Market Share Forecast by Type (2021-2025)
Figure 59. Global 50 mg per vial Revenue Growth Rate (2015-2020)
Figure 60. Global 100 mg per vial Revenue Growth Rate (2015-2020)
Figure 61. Global Anidulafungin Revenue Share by Application (2015-2020)
Figure 62. Global Anidulafungin Revenue Share by Application in 2019
Figure 63. Global Anidulafungin Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Drug store Revenue Growth Rate (2015-2020)
Figure 66. Global Anidulafungin Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Anidulafungin Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Anidulafungin Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Anidulafungin Revenue Market Forecast (2021-2025)
Figure 70. Europe Anidulafungin Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Anidulafungin Revenue Market Forecast (2021-2025)
Figure 72. South America Anidulafungin Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Anidulafungin Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---